ARG1 and metabolic dysfunction-associated steatohepatitis: From previous studies, in high fat diet rodent NASH model, decreased NO bioavailability coupled with changes in two key NO metabolic enzymes, suppression of activated eNOS and increase of ARG1, has been reported in steatotic livers [25].